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Abstract
Steady-state analysis of nucleotide-binding sites on rat liver plasma membranes was carried out using 3H-labelled ATP as
radioligand under complete inhibition of ecto-ATPase activity by excess EDTA. Binding of [3H]ATP to the membranes is
saturable, reversible and apparently involves one population of specific binding sites with Kd of about 90 nM and binding
capacity (Bmax) of 15 pmol/mg protein. A broad spectrum of purinergic agonists and antagonists was examined as potential
inhibitors of the measured binding. The displacement studies showed the following rank order of inhibitory potency for
[3H]ATP-binding sites (pIC50 values in parentheses) : ATPQS (7.49)s 2-MeSATP (7.18)sATP (6.91)sADPLS
(6.64)vADP (6.56)ERB2 (6.14)Esuramin (5.40)EAp4A (4.57)sK,L-MeATP (4.19)vL,Q-MeATP (3.97). AMP,
adenosine, Ap5A, PPADS, L-glycerophosphate as well as non-adenine nucleoside triphosphates GTP, UTP and CTP did
not exert any effect on the measured binding at concentration ranges of 1036^1034 M. In order to ascertain whether ATP and
its analogues are capable of interacting with the same binding domain, 2-MeSATP and ADP were treated as alternative
ligands that could compete with unlabelled ATP for its binding sites. A 2-fold increase of Kd value for ATP-receptor
interaction was observed in the presence of 2-MeSATP (60 nM) or ADP (250 nM) without any modulation of Bmax value,
confirming that inhibitory effects of these compounds are competitive in nature. These studies demonstrate that ATP and its
analogues are able to interact with a single binding domain on liver plasma membranes, which may be identified as ligand-
binding component of P2 purinoceptors of the P2Y1 subtype. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Extracellular adenine nucleotides are widely ac-
cepted as e¡ectors of signal transduction processes
mediating signalling events in various tissues through
P2 purinoceptors, whilst adenosine acts via P1 recep-
tors [1^3]. This receptor classi¢cation was originally
suggested by Burnstock [4] and then supplemented
on the basis of agonist potency order and signal
transduction mechanisms by the description of a
number of di¡erent subtypes including P2X, P2Y,
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Abbreviations: ADPLS, adenosine 5P-O-(2-thiodiphosphate);
Ap4A, diadenosine 5P,5R-P1,P4-tetraphosphate; Ap5A, diadeno-
sine 5P,5R-P1,P5-pentaphosphate; ATPQS, adenosine 5P-O-(3-thio-
triphosphate) ; 2-MeSATP, 2-methylthio-ATP; K,L-MeATP, K,L-
methylene ATP; L,Q-MeATP, L,Q-methylene ATP; EDTA, ethyl-
enediaminetetraacetic acid (disodium salt) ; PPADS, pyridoxal-
phosphate-6-azophenyl-2P,4P-disulphonic acid; RB2, Reactive
blue 2 (Cibacron blue 3GA); SDS, sodium dodecyl sulphate;
TLC, thin-layer chromatography
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P2T, P2Z, P2U and P2D [5,6]. More recently, all of
these subtypes have been categorized into two main
families: a P2X family consisting of ligand-gated cat-
ion channels; and a P2Y family consisting of G pro-
tein-coupled receptors [3,7]. Although the pharma-
cology and physiology of P2 purinoceptors have
been intensively investigated, studies of kinetic char-
acteristics of these receptors are always complicated
by rapid dephosphorylation of the exogenously ap-
plied or endogenously released ATP by plasma mem-
brane ecto-ATPases [8,9]. Approaches to overcome
this problem have involved the search for either
non-hydrolysable P2 agonists and antagonists or ap-
propriate compounds inhibiting membrane ecto-
ATPase activity.
Since phosphonates containing K,L- or L,Q-methyl-
ene substituents have been shown to be relatively
resistant to enzymatic hydrolysis and are considered
the most active agonists for P2X receptors [5,6],
[3H]K,L-MeATP has been used in our laboratories
to determine kinetic parameters and distribution of
P2X receptors in bladder and vas deferens mem-
branes [10^12]. Substitution of a phosphate group
by a thiophosphate group also signi¢cantly increases
resistance of the nucleotide to the ecto-nucleotid-
ase activity, therefore [35S]ATPQS [13,14] and
[35S]ADPLS [15,16] have been used as potential
radioligands for P2Y purinoceptors. Although a
number of reports have suggested successful label-
ling of P2 purinoceptors [6,10^18], comprehensive
comparison of these data is limited by lack of
a uniform approach and diversity of radioligands
used.
For estimation of ‘true’ kinetic mechanisms of
ATP-receptor interaction on the cellular surface it
would be useful if the ecto-ATPases had a speci¢c
inhibitor of their own. Several compounds inhibiting
ecto-ATPase activity have been examined as poten-
tially valuable probes in P2 receptor studies [9,19^22]
although none were found to be selective. Moreover,
the possibility exists that ecto-ATPase and P2 recep-
tors have very similar nucleotide-binding domains
[20,23], therefore simple competitive displacement
of the ligand and a reduction of its concentration
in the vicinity of the receptor in the presence of se-
lective ATPase inhibitor cannot be excluded. From
this viewpoint, non-speci¢c inhibition of the enzymes
may be considered as a more preferable tool. Such
compounds as paraformaldehyde [24], glycerol
[25,26] and EDTA [14,16,27] were used for determi-
nation of nucleotide-binding parameters under parti-
al or complete inhibition of certain ecto-nucleotidase
activity.
In the present work, the chelating agent EDTA
was examined as suitable non-speci¢c inhibitor of
ecto-ATPase activity to aid kinetic and competitive
analysis of nucleotide-binding sites on rat liver plas-
ma membranes using [3H]ATP as radioligand and a
broad spectrum of P2 receptor agonists and antago-
nists.
2. Materials and methods
2.1. Materials and equipment
2-MeSATP was from Research Biochemicals,
PPADS was from Tocris Cookson Chemical. [2,8-
3H]ATP with speci¢c activity 40 Ci/mmole was pur-
chased from ICN Biomedicals (Belgium). Organic
solvents were from Analar. Glass micro¢bre ¢lters
GF/B were from Whatman (UK). Liquid scintillation
cocktail Wallac OptiPhase ‘HiSafe’-3 was from Fish-
er Chemical. TLC plates were 20U10 cm silica gel 60
F254 type supplied by Sigma-Aldrich Chemicals. All
other chemicals were purchased from Sigma Chem-
icals (Poole, UK).
The following Beckman equipment was used
throughout the present studies: DU-65 spectropho-
tometer with programming QUANT-II Soft-Pack
Module; J2-MC centrifuge with JA-20 rotor and Op-
tima L-70 preparative ultracentrifuge with SW-41
bucket rotor; LS6000IC liquid scintillation spec-
trometer.
2.2. Liver plasma membrane isolation
Male Sprague-Dawley rats weighing 200^220 g
were killed by asphyxiation with CO2. The liver
was perfused with saline through the portal vein
for blood clearance, removed from the animal and
placed in an ice-cold 1 mM borate bu¡er, containing
0.5 mM CaCl2 (pH 7.5). About 5 g of the tissue was
cut into small pieces, passed through 0.5 mm press-
sieve and dispersed in glass homogenizer with te£on
pestle. Further separation of plasma membrane frac-
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tions from the bulk of contaminating mitochondria
and microsomes was performed by a series of di¡er-
ential and isopycnic centrifugations as described pre-
viously [28]. The resulting membrane pellet was sus-
pended in 7 mM Tris-HCl (pH 7.4) at 2^2.5 mg
protein/ml and stored in aliquots in liquid nitrogen.
Aliquots were used within 1 month following the
preparation, thawed on a water bath at 37‡C just
before the experiment.
After ¢rst centrifuging of the crude liver homoge-
nate at 150Ug for 10 min and discarding of the
nuclear pellet, aliquots of the supernatant homoge-
nate were also sampled and stored in liquid nitrogen
until used in comparative enzyme and binding as-
says.
2.3. Measurement of [3H]ATP binding to membranes
Plasma membranes (30^35 Wg protein) were incu-
bated for 5 min at 37‡C in a ¢nal volume of 200 Wl in
the medium containing 50 mM Tris-HCl (pH 7.4), 30
mM EDTA, [3H]ATP (approx. 106 dpm), unlabelled
ATP (0^1000 nM) and various concentrations of oth-
er agents (in the case of competitive studies). The
reaction was terminated by addition of 4 ml phos-
phate bu¡er (5 mM, pH 7.4) followed by rapid ¢l-
tration through GF/B ¢lters and subsequent 2-fold
washing with phosphate bu¡er. The ¢lters were
staged overnight with 5 ml of scintillation cocktail
and counted on a L-spectrometer. Speci¢c binding
was determined as the di¡erence between total and
non-speci¢c binding (measured in the presence of 10
WM ATP) and it was no less than 85% of the total
binding.
2.4. Enzyme assays
TLC assay has proved to be one of the most con-
venient and versatile methods for screening the ad-
enine nucleotide catabolism [8], and therefore this
approach was used both for determination of speci¢c
activity of ecto-ATPase (EC 3.6.1.15) and for estima-
tion of the extent of [3H]ATP degradation in the
course of its binding to membranes. For ecto-ATP-
ase assay the specimens were incubated for 10^15
min at 37‡C in a ¢nal volume of 50 Wl containing
either 50 Wg of homogenate or 5^7 Wg of plasma
membrane protein, 1 mM ATP with tracer [3H]ATP
(5U105 dpm), 100 mM Tris-HCl (pH 7.4), 5 mM
MgCl2, 200 WM ouabain and 5 mM NaN3. To char-
acterize the extent of [3H]ATP degradation, the stud-
ies were conducted either as described for the binding
assays (see Section 2.3) or with 5 mM MgCl2 instead
of 30 mM EDTA. In both cases the reaction was
terminated by applying aliquots of the mixture (6
Wl) on TLC sheets following the application of stand-
ard solution containing 2 mM ATP, ADP, AMP
and adenosine on the same spot. ATP and its de-
rivatives were separated by TLC with isobutyl alco-
hol/isoamyl alcohol/2-ethoxyethanol/ammonia/H2O
(9:6:18:9:15) as solvent [29] and visualized in UV
light. The spots corresponding to ATP were scraped
into scintillation vials followed by 1 h extraction of
the nucleotide from the silica using 0.8 ml 0.1 N HCl.
The residual [3H]ATP was quanti¢ed by scintillation
counting after an overnight incubation with 5 ml
scintillation cocktail.
5P-Nucleotidase activity (EC 3.6.1.5) was assayed
as previously described [26] and inorganic phosphate
liberated after AMP hydrolysis was detected turbidi-
metrically [30].
2.5. Protein assay
Protein was determined by a modi¢ed Lowry
method [31] using bovine serum albumin as standard
after pre-incubation of the membrane samples with
1% SDS at 37‡C for 45 min.
2.6. Data analysis
The maximum binding capacity (Bmax) and the dis-
sociation constant (Kd) for ATP-binding sites were
determined using EBDA-LIGAND software
(McPherson BioSoft, Cambridge, UK). Data from
competition-binding experiments were subjected to
computer analysis by non-linear least-squares curve
¢tting (GraphPad Prism software) to determine IC50
values. Objective statistical criteria (F-test, extra sum
of squares principle) were used to evaluate goodness
of ¢t and for discriminating between one-site and
two-site binding models.
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3. Results
3.1. Determination of equilibrium conditions for
[3H]ATP binding to membranes
As shown in Fig. 1, rapid enzymatic dephospho-
rylation of [3H]ATP (50 nM) was observed within
the ¢rst minute after incubation with liver mem-
branes, so that all attempts to detect any amount
of the membrane-bound [3H]ATP by binding assay
showed radioactivity of the ¢lters comparable with
blank values. In the presence of 30 mM EDTA com-
plete inhibition of ATPase activity was achieved (Fig.
1) and binding of [3H]ATP to plasma membranes in
these conditions reached a plateau value after 3^4
min and remained unchanged for at least 10 min
(Fig. 2). When 3H-labelled and unlabelled ATP (10
WM) were introduced to the assay bu¡er separately at
5 min interval, a gradual decrease of [3H]ATP bind-
ing ensued (Fig. 2), indicating the reversible charac-
Table 1
Comparison of 5P-nucleotidase and ecto-ATPase speci¢c activities and [3H]ATP-binding capacity in rat liver homogenate and plasma
membrane preparations
Preparation 5P-Nucleotidase (Wmol Pi/mg/h) Ecto-ATPase (Wmol ATP/mg/h) [3H]ATP binding (dpm/mg (U103))
Homogenate 1.06 þ 0.13 (5) 1.52 þ 0.21 (3) 60.5 þ 11.4 (3)
Plasma membranes 13.80 þ 0.22 (8) 18.24 þ 0.52 (6) 545.0 þ 58.0 (6)
Ecto-ATPase and 5P-nucleotidase assays were carried out as described in Section 2.4 using either 50 Wg of liver crude homogenate or
5^7 Wg of puri¢ed plasma membranes and expressed as Wmole of substrate hydrolysed by mg protein per hour. [3H]ATP-binding as-
says were performed as described in Section 2.3 either with liver homogenate (50^250 Wg/sample) or plasma membranes (10^45 Wg/
sample) (see Fig. 3) and the relative binding capacity was expressed as the amount of speci¢c radioactivity bound per mg protein. Val-
ues are the mean þ S.E.M. with the number of experiments shown in parentheses.
Fig. 2. Association-dissociation pattern for speci¢c [3H]ATP
binding to rat liver plasma membranes. The association curve
was obtained by incubation of the membranes with [3H]ATP
(50 nM) at 37‡C in 50 mM Tris bu¡er supplemented with 30
mM EDTA for the indicated times. Following [3H]ATP, excess
ATP (10 WM) was added to the assay bu¡er 5 min later (indi-
cated by arrow) and the time course of the membrane-bound
[3H]ATP dissociation is also shown by the dotted line. The or-
dinate shows the value of speci¢c [3H]ATP binding determined
by subtracting non-speci¢c binding from total binding ¢gures.
Data represent means þ S.E.M. of three experiments performed
in duplicate.
Fig. 1. Enzymatic hydrolysis of [3H]ATP by rat liver plasma
membranes. The membranes (30 Wg protein) were incubated at
37‡C with 50 nM [3H]ATP in 50 mM Tris bu¡er (pH 7.4) con-
taining either 30 mM EDTA or 5 mM MgCl2 in the starting
volume of 0.2 ml. Aliquots of the reaction mixture (6 Wl) were
periodically applied on TLC sheets for separation of the
[3H]ATP and its derivatives (Section 2.4). The residual [3H]ATP
after ATPase reaction is expressed on the ordinate as percent-
age of the initial concentration. The graphs show mean data
(n = 3); the standard error of the mean did not exceed the size
of symbols.
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ter of the nucleotide-binding process in the presence
of EDTA.
The quantity of [3H]ATP bound to plasma mem-
branes increased proportionally with protein concen-
tration over the range 10^45 Wg (Fig. 3) and the
relative amount of radioactivity bound per mg of
membrane protein was about 9-fold higher than
that for the crude homogenate containing substantial
amounts of non-plasma membrane material (Table
1). Comparison of this value with the 12-fold extent
of plasma membrane enrichment, as evaluated by
enzyme markers 5P-nucleotidase and ecto-ATPase
(Table 1), testi¢es that the measured ATP binding
is predominately associated with plasma membranes
rather than with other subcellular fractions. No
[3H]ATP binding was observed after preliminary
treatment of the membranes with K-chymotrypsin
(5 Wg/sample; 10 min at 37‡C), suggesting that nu-
cleotide interaction with plasma membranes occurred
at speci¢c protein domains.
3.2. Kinetic analysis of [3H]ATP interaction with
plasma membranes
Steady-state analysis of ATP-receptor interaction
was performed by adding [3H]ATP and increasing
concentrations of unlabelled ATP until saturation
was achieved (Fig. 4). Graphical representation of
this binding isotherm in a Scatchard plot showed
linear dependence (Fig. 5). The kinetic constants
(Kd and Bmax) were determined by computer analysis
using a model of single binding site with non-speci¢c
binding and are summarized in Table 2.
It should be noted that the amount of [3H]ATP
bound to membranes in the presence of excess ATP
(10 WM) did not signi¢cantly exceed the blank values
determined in the absence of plasma membrane pro-
tein. These data indicate that the detected non-spe-
ci¢c binding of [3H]ATP is primarily conditioned by
partial adsorption of radioligand on the GF/B ¢lters
during ¢ltration procedure, and not by non-speci¢c
interaction with any membrane proteins or low-a⁄n-
ity binding to another class of ATP receptors on liver
plasma membranes.
Fig. 4. Competitive inhibition of [3H]ATP binding by purinergic
ligands. The membranes were incubated with [3H]ATP (50 nM)
and increasing concentrations of unlabelled agents. The results
are plotted as the percentage of maximal [3H]ATP binding,
measured in the absence of competitors. Means þ S.E.M. from
three experiments performed in duplicate.
Fig. 3. Linearity of [3H]ATP binding to rat liver plasma mem-
branes with protein concentration. Increasing concentrations of
plasma membrane protein (0^45 Wg) were incubated for 5 min
at 37‡C in the ¢nal volume of 0.2 ml, containing 50 nM
[3H]ATP, 50 mM Tris (pH 7.4) and 30 mM EDTA. The ordi-
nate shows the value of total [3H]ATP binding. Data represent
means þ S.E.M. of three experiments performed in duplicate.
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3.3. Competitive analysis of [3H]ATP binding to
plasma membranes
Addition of various P2Y agonists (Fig. 4A) and
the P2 antagonists RB2 and suramin (Fig. 4B) to
the assay bu¡er was accompanied by concentra-
tion-dependent inhibition of [3H]ATP binding to
membranes indicating the measurement of the radio-
ligand binding to P2 receptors by this protocol. The
diadenine nucleotide Ap4A and the P2X agonists
K,L-MeATP and L,Q-MeATP were much less potent
competitors (Fig. 4B) whereas AMP, adenosine,
Ap5A, PPADS, L-glycerophosphate, GTP, UTP
and CTP did not exert any inhibitory e¡ect at con-
centration ranges of 1036^1034 M (data not shown).
The pIC50 values were calculated from competition
binding curves using one-site model and are summa-
rized in Table 3. Overall, the displacement stud-
ies showed that the rank order of inhibitory po-
tency for [3H]ATP-binding sites was ATPQSs
2-MeSATPsATPsADPLSvADPERB2Esura-
minEAp4AsK,L-MeATPv L,Q-MeATP.
In order to check whether ATP and its analogues
interact with the same binding domain, the most
commonly used P2Y agonists 2-MeSATP and ADP
[5^7] were treated as alternative ligands that could
compete with unlabelled ATP for its binding sites.
Table 3
Competitive analysis of [3H]ATP binding to rat liver plasma
membranes
Ligand pIC50
ATPQS 7.492 þ 0.043
2-MeSATP 7.181 þ 0.044
ATP 6.915 þ 0.027
ADPLS 6.640 þ 0.031
ADP 6.565 þ 0.028
RB2 6.143 þ 0.049
Suramin 5.396 þ 0.044
Ap4A 4.569 þ 0.053
K,L-MeATP 4.195 þ 0.037
L,Q-MeATP 3.970 þ 0.044
The binding of 50 nM [3H]ATP to liver membranes was inhib-
ited by increasing concentrations of the indicated ligand. Bind-
ing competition curves were constructed (see Fig. 4) and ¢tted
to a one-site model using non-linear least-squares curve ¢tting
in GraphPad Prism. The constants are expressed in terms of
pIC50 (3log IC50) þ S.E.M. for three independent experiments.
Table 2
Kinetic parameters of [3H]ATP binding to rat liver plasma membranes and their modi¢cation in the presence of 2-MeSATP and ADP
as alternative ligands
Alternative ligand Concentration of the ligand (nM) ATP-binding parameters
Bmax (pmol/mg protein) Kd (nM)
None (control) ^ 14.96 þ 0.85 88.2 þ 9.4
ADP 250 16.37 þ 1.21 180.9 þ 20.0*
2-MeSATP 60 15.8 þ 1.80 227.8 þ 31.5*
For determination of nucleotide-binding parameters plasma membranes were incubated with [3H]ATP and increasing concentrations
of the unlabelled ATP in the absence (control) or presence of the ¢xed concentration of certain inhibitor. The number of nucleotide-
binding sites (Bmax) and dissociation constant (Kd) were calculated from the corresponding Scatchard plots (see Fig. 5) by a com-
puter-adapted least-squares method. Values are the mean þ S.E.M. of three to six experiments. Student’s t-test was employed to com-
pare the di¡erence between means. *P6 0.05 as compared with control.
Fig. 5. Scatchard analysis of [3H]ATP binding to liver plasma
membranes in the presence of 2-MeSATP and ADP as alterna-
tive ligands. The membranes were incubated with 50 nM
[3H]ATP and unlabelled ATP (0^1000 nM) in the absence (con-
trol) or presence of 2-MeSATP (60 nM) or ADP (250 nM).
Data are plotted as speci¢cally bound radioligand (abscissa)
versus bound ligand divided by total ligand concentration (ordi-
nate). The data are the mean of duplicate assays from a repre-
sentative experiment, which was repeated at least three times.
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In the presence of ¢xed concentrations of 2-MeSATP
(60 nM) or ADP (250 nM) saturation curves for
[3H]ATP binding to liver membranes were shifted
to the right as the concentration of unlabelled ATP
was increased. Scatchard transformation of these
data is presented in Fig. 5. Computer analysis of
the binding isotherms revealed a 2-fold increase of
Kd value in the presence of 2-MeSATP and ADP
without any modi¢cation of binding capacity, Bmax
(Table 2), con¢rming that inhibitory e¡ects of these
ATP analogues are competitive in nature.
4. Discussion
4.1. Kinetic and competitive analysis of ATP binding
to plasma membranes
Understanding the dynamic biochemistry of P2 re-
ceptors requires development of truly reliable bind-
ing assays for their direct quantitation, and the data
presented above suggest that the chelating agent
EDTA can be readily used for this purpose. Addition
of excess EDTA to the assay bu¡er was accompanied
by complete inhibition of ecto-ATPase activity with
respective stabilization of the nucleotide-binding
process and in this way, steady-state binding of na-
tive [3H]ATP to rat liver plasma membranes was
carried out. Binding of ATP to the membranes is
saturable, reversible and apparently involves one
population of nucleotide-binding sites with Kd of
about 90 nM and Bmax of 15 pmol/mg protein.
Various nucleotide analogues were examined as
potential inhibitors of the measured [3H]ATP bind-
ing, including P2Y agonists, 2-MeSATP, ATPQS,
ADPLS and ADP [5^7,32^34]; P2X agonists, K,L-
MeATP and L,Q-MeATP [5^7]; diadenosine poly-
phosphates, Ap4A and Ap5A, which act as physio-
logically signi¢cant purinergic agonists at both P2X
and P2Y receptors [22,35,36]. P2Y agonists were in
equimolar competition with [3H]ATP for its binding
sites with the following rank order of inhibitory
potency: ATPQS s 2-MeSATP sATP sADPLSv
ADP. Moreover, the a⁄nity of ATP-binding sites
was markedly reduced in the presence of 2-MeSATP
and ADP as alternative ligands, indicating that dis-
placement e¡ects of these ATP analogues are caused
by true competition with ATP for the common bind-
ing domain, and not by any allosteric constraints in
the course of their interaction with other binding
sites in the vicinity of ATP receptors. K,L-MeATP,
L,Q-MeATP and Ap4A were less potent competitors,
whereas Ap5A, AMP, adenosine and non-adenine
nucleoside triphosphates did not cause any displace-
ment. It may be concluded that both the adenine ring
and an unmodi¢ed phosphate chain with two or
three phosphate groups are involved in the nucleo-
tide interaction with these binding sites.
Several P2 antagonists with di¡erent selectivities
for P2 receptor subtypes were also examined in our
binding studies. The trypanocide suramin and the
dye RB2, which have been widely employed as P2Y
antagonists [5,21,23], were capable of inhibiting
[3H]ATP binding to plasma membranes at a compar-
able concentration range (1036^1035 M) as in phar-
macological studies, suggesting that antagonistic ef-
fects of these compounds may be explained by direct
competition with ATP for receptor sites. With anoth-
er compound tested, PPADS, a putative antagonist
of both P2Y and P2X receptors in various tissues
[5,21,22], we were unable to detect any inhibitory
e¡ects even at concentration up to 50 WM.
4.2. Comparison with other liver radioligand-binding
assays
ATP-binding sites were initially described in rat
liver plasma membranes and hepatocytes using
[35S]ATPKS as radioligand [17] and reported later
in human liver plasma membranes and in rabbit
and guinea pig hepatocytes (see [18]). Although
[35S]ATPKS-binding studies with rat liver membranes
also revealed one binding component with Kd 230
nM and Bmax 30 pmol/mg protein [17], the most po-
tent P2Y agonist 2-MeSATP possessed little a⁄nity
for these receptor sites [34]; in addition, a ‘non-sat-
urable’ binding component of unknown physiologi-
cal signi¢cance was detected. A disadvantage of
ATPKS is its liability to enzymatic breakdown, so
that steady-state conditions may be achieved only
within the ¢rst minute of incubation.
Despite binding studies with the more stable
[35S]ATPQS having been performed on rat liver plas-
ma membranes (IC50 for ATP, 600 nM) [13], identi-
¢cation of these receptors was limited by progressive
non-speci¢c binding of the radioligand with other
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membrane proteins. Another non-hydrolysable ra-
dioligand [35S]ADPLS has been used for labelling
of P2Y receptors on rat liver parenchymal cells
[16]. However, determination of the Kd value in these
binding studies was precluded by high Ki value for
unlabelled ADPLS (1.8 WM). Moreover, displace-
ment data obtained with these non-hydrolysable
ATP analogues do not conform to the a⁄nity pro¢le
of known P2 receptors [6,13,14], which may be ex-
plained by di¡erences in catabolism of the radio-
ligand and unlabelled agonists.
Use of EDTA for complete inhibition of enzymatic
breakdown of ATP and its analogues confers certain
advantages compared with other binding assays.
First, kinetic parameters of nucleotide-receptor inter-
action may be performed with native ATP as a ‘kin-
dred’ ligand of P2 receptors and second, nucleotide-
binding sites may be subdivided on the basis of rel-
ative order of potency of native ATP displacement
by a series of purinergic agonists and antagonists.
4.3. Evaluation of physiological relevance of the
described binding sites
Although the system described provides a useful
model for steady-state analysis of nucleotide-receptor
interaction on the cellular surface, it is not possible
to perform signal transduction processes under sim-
ilar conditions. Therefore, comparison of the binding
constants with receptor activity constants may be
considered a useful tool to establish whether these
binding sites constitute a physiologically relevant re-
ceptor.
The most prominently described second messenger
response to P2Y1 receptor activation in liver is acti-
vation of the rate-limiting enzyme of glycogenolysis
glycogen phosphorylase and mobilization of intracel-
lular calcium which was originally described by
Charest et al. [32]. Summarizing the literature data
concerning activation of glycogen phosphorylase in
isolated hepatocytes by various P2Y agonists [32^36]
reveals the following rank order of potency: 2-
MeSATPsADPvATPsAp3AsAp4A. Other re-
sponses mediated by ATP and its analogues in liver
include accumulation of cyclic AMP, K uptake, ac-
tivation of phospholipases C and D, release of eico-
sanoids, phospholipid base exchange, etc.
[1,13,18,33,37]. In contrast to glycogenolytic e¡ects
(detected within the ¢rst 10^20 s), these responses
were assayed after longer incubation period and
100^1000-fold higher ATP concentrations were re-
quired to induce e¡ects.
There is a good correlation between ability of ATP
analogues to induce glycogenolytic e¡ects in isolated
hepatocytes and their relative potency for [3H]ATP
displacement in our studies with isolated liver plasma
membranes. Moreover, both e¡ects were observed
over the comparable concentration range suggesting
that identical sites have been labelled. On the basis of
this correlation it may be speculated that the de-
scribed nucleotide-binding sites represent a speci¢c
binding component of P2 receptors (presumably of
P2Y1 subtype), directly participating in the puriner-
gic action of ATP and ADP on liver metabolism.
Some features of the single binding sites that we
have revealed are not consistent with the hypothesis
that multiple receptors for ATP exist in liver [18].
These apparent discrepancies may be due to linkage
of a single nucleotide-binding domain to multiple
second messenger signalling pathways. Alternatively,
the possibility that at higher concentrations (1035^
1034 M) ATP can mediate certain responses through
other ‘non-purinergic’ receptor sites cannot be ex-
cluded.
4.4. Assessment of EDTA suitability for
nucleotide-binding studies
Another question concerning the reliability of the
proposed procedure is the presence of EDTA in the
assay bu¡er and the absence of Mg2 and other cat-
ions. Cooper et al. [15] noticed that in the presence of
MgCl2 the binding of [35S]ADPLS to P2 receptors on
turkey plasma membranes was not readily saturable,
whereas omission of Mg2 revealed a saturable high
a⁄nity binding site and signi¢cantly increased radio-
ligand binding to membranes. Similar results were
obtained more recently in kinetic experiments on
[3H]KL-MeATP binding to P2X receptors in human
urinary bladder [11], where withdrawal of Mg2
from the incubation medium drastically increased
the nucleotide-binding capacity of the membrane
preparations. Binding of various labelled ATP ana-
logues to high-a⁄nity binding sites was increased in
the presence of 1 mM EDTA and, what is more, this
chelating agent prevented interaction of the ligands
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with non-speci¢c binding sites and signi¢cantly re-
duced their enzymatic breakdown [14,16]. The fore-
going data indicate that P2 receptors are activated by
a form of ATP uncomplexed to divalent cations (pre-
sumably ATP43) and not by ATP-Mg2, which pre-
dominates in biological £uids and constitutes the
substrate of ATPases and kinases [38,39]. As such,
it may be assumed that complete withdrawal of the
residual Mg2 by EDTA will not be accompanied by
any signi¢cant modulation of nucleotide-binding pa-
rameters.
4.5. Concluding remarks
In summary, these studies (a) provide accurate pa-
rameters for the binding of native [3H]ATP to cellu-
lar surface in the absence of complications arising
from the further metabolism of the radioligand; (b)
establish the relative order of potency of [3H]ATP
displacement by a broad spectrum of purinergic
agents; (c) demonstrate that both ATP and its ana-
logues 2-MeSATP and ADP are able to interact with
a common binding domain on liver plasma mem-
branes; (d) suggest that the described binding sites
are linked to P2Y1 receptors, mediating, in particu-
lar, ATP/ADP-induced activation of liver glycogen-
phosphorylase and accumulation of intracellular
Ca2.
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